(NURE) Nuveen Short-Term REIT - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US67092P7069

NURE: Real Estate, REITs, Equity, Investment, Assets

Nuveen Short-Term REIT ETF (BATS:NURE) is an exchange-traded fund that focuses on investing at least 80% of its net assets and borrowings in Real Estate Investment Trusts (REITs) that meet specific criteria. The underlying index is a subset of the Dow Jones U.S. Select REIT Index, comprising equity REITs listed on U.S. national securities exchanges, deriving at least 75% of their revenue from owning and operating real estate assets, and having a minimum market capitalization of $200 million.

The funds investment strategy is centered around REITs that are primarily involved in the ownership and operation of real estate assets, providing a relatively focused exposure to the real estate sector. As a non-diversified fund, NURE may have a higher concentration risk compared to diversified funds, which could result in higher volatility.

Analyzing the , we observe that NUREs last price is $30.70, with short-term moving averages (SMA20 and SMA50) indicating a slight uptrend, as the price is above both the $30.24 and $30.09 levels. However, the long-term SMA200 at $31.64 suggests that the ETF is currently trading below its longer-term trend. The Average True Range (ATR) of $0.60, or 1.97%, indicates moderate volatility. Considering the 52-week high and low of $34.16 and $26.98, respectively, NURE is currently trading near the middle of its recent price range.

Combining the insights from and , we can infer that NUREs Assets Under Management (AUM) of $44.42 million may limit its liquidity and potentially impact its ability to efficiently track its underlying index. However, its current price action and technical indicators suggest a potential for short-term gains if the uptrend continues. A forecast based on these factors could be that NURE may experience a short-term price increase, potentially targeting the $31.64 SMA200 level, provided that the overall real estate sector and broader market conditions remain favorable.

To validate this forecast, it is crucial to monitor the funds tracking error, changes in AUM, and shifts in the underlying index composition. Additionally, keeping a close eye on interest rates, real estate market trends, and overall economic conditions will be essential in assessing NUREs future performance.

Additional Sources for NURE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

NURE ETF Overview

Market Cap in USD 44m
Category Real Estate
TER 0.35%
IPO / Inception 2016-12-19

NURE ETF Ratings

Growth Rating 17.1
Fundamental -
Dividend Rating 63.3
Rel. Strength -11.6
Analysts -
Fair Price Momentum 28.90 USD
Fair Price DCF -

NURE Dividends

Dividend Yield 12m 3.62%
Yield on Cost 5y 5.70%
Annual Growth 5y 7.54%
Payout Consistency 82.5%
Payout Ratio %

NURE Growth Ratios

Growth Correlation 3m 2.9%
Growth Correlation 12m -44.8%
Growth Correlation 5y 30.5%
CAGR 5y 9.20%
CAGR/Max DD 5y 0.26
Sharpe Ratio 12m 0.86
Alpha -7.50
Beta 0.582
Volatility 18.49%
Current Volume 1.9k
Average Volume 20d 4.1k
What is the price of NURE shares?
As of June 24, 2025, the stock is trading at USD 30.32 with a total of 1,851 shares traded.
Over the past week, the price has changed by +0.96%, over one month by +3.21%, over three months by -2.79% and over the past year by +0.18%.
Is Nuveen Short-Term REIT a good stock to buy?
Neither. Based on ValueRay´s Analyses, Nuveen Short-Term REIT is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 17.13 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NURE is around 28.90 USD . This means that NURE is currently overvalued and has a potential downside of -4.68%.
Is NURE a buy, sell or hold?
Nuveen Short-Term REIT has no consensus analysts rating.
What are the forecasts for NURE share price target?
According to our own proprietary Forecast Model, NURE Nuveen Short-Term REIT will be worth about 32.2 in June 2026. The stock is currently trading at 30.32. This means that the stock has a potential upside of +6.17%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 32.2 6.2%